MAIA Biotechnology (MAIA) to Release Earnings on Thursday

MAIA Biotechnology (NYSEAMERICAN:MAIA) is anticipated to release its earnings data before the market opens on Thursday, March 20th. Analysts expect MAIA Biotechnology to post earnings of ($0.20) per share for the quarter.

MAIA Biotechnology Price Performance

MAIA stock opened at $1.67 on Tuesday. MAIA Biotechnology has a 52-week low of $1.46 and a 52-week high of $5.99. The company’s 50 day moving average price is $1.92. The firm has a market capitalization of $43.69 million, a price-to-earnings ratio of -1.21 and a beta of 0.20.

MAIA Biotechnology Company Profile

MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer.